You can narrow down the results using the filters
-
ThromboView Phase Ib PE Extension Study
-
Enhancing health after surgery for breast cancer
This program intends to compare the effectiveness of two health programs (one an intervention program, one an active control) for enhancing the quality of life of women who have undergone surgery for breast cancer in the 6 months following surgery.
-
The Role of COMT (Catechol-O-Methyltransferase) Inhibition in Treating Non-Motor Fluctuations in Parkinson’s Disease
-
A randomised comparative crossover study to assess the affect on circuit life of varying pre-dilution volumes associated with Continuous Veno-Venous Haemofiltration (CVVH) and Continuous Veno-Venous Haemodiafiltration (CVVHDF).
Please see attachment for summary of study's findings. Davies HT, Leslie G, Pereira SM, Webb SAR. A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDf. The International Journal of Artificial Organs. 31 (3); 221-227.
-
balANZ Study: A multicentre, randomised, controlled trial to determine whether peritoneal dialysis treatment with a low GDP, neutral pH peritoneal dialysis (PD) solution (balance) compared to standard PD solution is associated with superior preservation of residual renal function.
-
Safety and Efficacy of Cpn10 in Rheumatoid Arthritis
Test the safety and effectiveness of Cpn10 in patients with rheumatoid arthritis. The study personnel, patient and sponsor are all blinded to which of the three doses of Cpn10 is administered.
-
The safety and efficacy of Cpn10 in psoriasis
Safety and effectiveness of Cpn10 in patients with moderate to severe psoriasis. Three doses of Cpn10 are being trialed. The study personnel performing the assessments, the sponsor and the patient are blinded to which of the three doses are administered.
-
Use of transthoracic echocardiography to assess left ventricular volume in total hip joint replacement.
-
The safety of Cpn10 in patients with multiple sclerosis
Safety of Cpn10 in patients with multiple sclerosis. The study personnel, patients and sponsor are all blinded as to whether the patient received either of the two doses being trialed or placebo.
-
A trial to determine if cooling newborn infants at risk of brain damage improves outcome